Ameliorative effects and mechanisms of Buyang huanwu decoction and its active fractions on non-alcoholic fatty liver disease

YANG Jinbiao; CHEN Xingtong; ZHOU Yunyue; YANG Ruihong; WANG Qiao; XUE Shuang; ZHANG Yukun; NIU Wenying

doi:10.6039/j.issn.1001-0408.2026.03.05

您当前的位置：

首页 >

文章列表页 >

Ameliorative effects and mechanisms of Buyang huanwu decoction and its active fractions on non-alcoholic fatty liver disease

更新时间：2026-02-11

- Ameliorative effects and mechanisms of Buyang huanwu decoction and its active fractions on non-alcoholic fatty liver disease
- ZHONGGUO YAOFANG Vol. 37, Issue 3, Pages: 299-304(2026)
- 作者机构：
  
  黑龙江中医药大学基础医学院，哈尔滨　150040
- 作者简介：
- 基金信息：
- DOI：10.6039/j.issn.1001-0408.2026.03.05
  CLC： R965
- Received：21 July 2025，
  
  Revised：2026-01-02，
  
  Accepted：14 January 2026，
  
  Published：15 February 2026
- 稿件说明：
移动端阅览
杨金彪,陈星彤,周云越,等.补阳还五汤及其有效部位改善非酒精性脂肪性肝病的作用及机制研究 [J].中国药房,2026,37(03):299-304.

YANG Jinbiao,CHEN Xingtong,ZHOU Yunyue,et al.Ameliorative effects and mechanisms of Buyang huanwu decoction and its active fractions on non-alcoholic fatty liver disease[J].ZHONGGUO YAOFANG,2026,37(03):299-304.
杨金彪,陈星彤,周云越,等.补阳还五汤及其有效部位改善非酒精性脂肪性肝病的作用及机制研究 [J].中国药房,2026,37(03):299-304. DOI： 10.6039/j.issn.1001-0408.2026.03.05.

YANG Jinbiao,CHEN Xingtong,ZHOU Yunyue,et al.Ameliorative effects and mechanisms of Buyang huanwu decoction and its active fractions on non-alcoholic fatty liver disease[J].ZHONGGUO YAOFANG,2026,37(03):299-304. DOI： 10.6039/j.issn.1001-0408.2026.03.05.

摘要

目的

研究补阳还五汤（BYHWD）及其有效部位改善非酒精性脂肪性肝病的作用及机制。

方法

制备BYHWD及其醇沉、30%乙醇、50%乙醇、75%乙醇有效部位（即CC、30YC、50YC、75YC有效部位），以此灌胃大鼠并制备相应含药血清（同法制备空白血清和辛伐他汀含药血清）。将人L02肝细胞分为对照组、模型组、辛伐他汀含药血清组、BYHWD含药血清组、CC含药血清组、30YC含药血清组、50YC含药血清组、75YC含药血清组。除对照组外，其余各组均加入0.2 mol/L油酸诱导24 h，以建立脂质沉积模型，再加入相应20%含药血清/空白血清干预24 h。观察细胞中脂质沉积情况，并计算脂滴面积占比；检测细胞中甘油三酯（TG）及氧化应激[丙二醛（MDA）、超氧化物歧化酶（SOD）]、肝功能[丙氨酸氨基转移酶（ALT）、天冬氨酸氨基转移酶（AST）]指标水平；检测细胞中AMP活化的蛋白质激酶（AMPK）/固醇调节元件结合蛋白1（SREBP-1）/甘油-3-磷酸酰基转移酶（GPAT）信号通路相关蛋白及mRNA表达水平。

结果

与对照组比较，模型组细胞脂肪变性严重，细胞中脂滴面积占比以及TG、ALT、AST、MDA水平和SREBP-1、GPAT mRNA及其蛋白表达水平均显著升高（

＜0.05），细胞中SOD水平、AMPK mRNA表达水平和AMPK蛋白磷酸化水平均显著降低（

＜0.05）。与模型组比较，各含药血清组细胞脂肪变性均减轻，上述大部分定量指标水平均被显著逆转（

＜0.05）。

结论

BYHWD及其有效部位可通过调控AMPK/SREBP-1/GPAT信号通路，抑制氧化应激反应，减轻脂质沉积，从而发挥改善非酒精性脂肪性肝病的作用。

Abstract

OBJECTIVE

To investigate the effects and mechanisms of Buyang huanwu decoction （BYHWD） and its active fractions in ameliorating non-alcoholic fatty liver disease.

METHODS

BYHWD and its effective fractions obtained through ethanol precipitation， as well as 30% ethanol， 50% ethanol， and 75% ethanol fractions （namely， the CC effective fraction， 30YC effective fraction， 50YC effective fraction， and 75YC effective fraction）， were prepared. These preparations were administered to rats via intragastric administration to prepare corresponding drug-containing serum （blank serum and simvastatin-containing serum were prepared using the same protocol）. Human L02 hepatocytes were divided into control group， model group， simvastatin-containing serum group， BYHWD-containing serum group， CC-containing serum group， 30YC-containing serum group， 50YC-containing serum group， and 75YC-containing serum group. Except for the control group， other groups were given 0.2 mol/L oleic acid for 24 h to induce a lipid accumulation model， and then intervened with 20% drug-containing serum/blank serum for 24 h. The lipid deposition in cells was observed， and the proportion of lipid droplet area was calculated； the levels of triglycerides （TG） and indicators of oxidative stress [malondialdehyde （MDA）， superoxide dismutase （SOD）] as well as liver function [alanine amino-transferase （ALT）， aspartate amino-transferase （AST）] in cells were detected； protein and mRNA expressions of AMP-activated protein kinase （AMPK）/sterol regulatory element-binding protein-1 （SREBP-1）/glycerol-3-phosphate acyltransferase （GPAT） signaling pathway were also measured.

RESULTS

Compared with the control group， cells in the model group exhibited severe cellular steatosis， with a significantly increased proportion of lipid droplet area， as well as the elevated levels of TG， ALT， AST， and MDA in cells， along with significantly up-regulated mRNA and protein expression levels of SREBP-1 and GPAT （

＜0.05）. The level of SOD， mRNA expression of AMPK， as well as the protein phosphorylation level of AMPK were decreased significantly （

＜0.05）. Compared with the model group， cellular steatosis was alleviated in all drug-containing serum groups， and the levels of most of the aforementioned quantitative indicators were significantly reversed （

＜0.05）.

CONCLUSIONS

BYHWD and its active fractions can exert a therapeutic effect on improving non-alcoholic fatty liver disease by regulating the AMPK/SREBP-1/GPAT signaling pathway， inhibiting oxidative stress responses， and reducing lipid deposition.

关键词

Keywords

references

杨金彪，陈星彤，周云越，等 . 基于Nrf2信号通路中药对代谢相关脂肪性肝病预防及治疗作用研究进展 [J ] . 药物评价研究， 2024 ， 47 （ 11 ）： 2681 - 2687 .

LE M H ， YEO Y H ， LI X H ， et al . 2019 global NAFLD prevalence：a systematic review and meta-analysis [J ] . Clin Gastroenterol Hepatol ， 2022 ， 20 （ 12 ）： 2809 - 2817.e28 .

CHRYSAVGIS L ， GIANNAKODIMOS I ， DIAMANTOPOULOU P ， et al . Non-alcoholic fatty liver disease and hepatocellular carcinoma：clinical challenges of an intriguing link [J ] . World J Gastroenterol ， 2022 ， 28 （ 3 ）： 310 - 331 .

高改娅，李莎，薛敬东，等 . 非酒精性脂肪性肝病中医证型及证素研究 [J ] . 临床肝胆病杂志， 2021 ， 37 （ 1 ）： 89 - 93 .

陈欢，徐陆周，黄芳 . 中药基于“肠-肝轴”防治非酒精性脂肪性肝病的研究进展 [J ] . 药学进展， 2024 ， 48 （ 11 ）： 849 - 859 .

潘雨晴，毛傲洁，于楚楚，等 . 中药有效成分及其复方防治非酒精性脂肪性肝病的现状与展望 [J ] . 临床肝胆病杂志， 2024 ， 40 （ 10 ）： 1933 - 1941 .

钱煜昊，卜献忠，郭晓辉，等 . 基于Nrf2/HO-1通路介导的铁死亡探讨补阳还五汤对脊髓损伤的保护作用 [J/OL ] . 中国实验方剂学杂志， 2025 ： 1 - 15 [ 2025-09-03 ] . https：//xueshu.baidu.com/ndscholar/browse/detail paperid=177q- 0js0gj3k06p0g95f0xs0v9362921 https://xueshu.baidu.com/ndscholar/browse/detailpaperid=177q-0js0gj3k06p0g95f0xs0v9362921 .

GUO J F ， ZHANG Y W ， ZHOU R ， et al . Deciphering the molecular mechanism of Buyang huanwu decoction in interference with diabetic pulmonary fibrosis via regulating oxidative stress and lipid metabolism disorder [J ] . J Pharm Biomed Anal ， 2024 ， 243 ： 116061 .

王昌明，史永奋，王丹华 . 补阳还五汤加减治疗脂肪肝59例临床疗效观察 [J ] . 中国中西医结合消化杂志， 2003 ， 11 （ 2 ）： 88 - 89 .

YANG S H ， ZHANG Y K ， LIU X X ， et al . Effects of different components of Buyang huanwu tang on the PPARγ/LXRα/ABCA1 pathway in hypercholesterolemia mouse model [J ] . Int J Genomics ， 2025 ， 2025 ： 9595757 .

BADI R M ， MOSTAFA D G ， KHALEEL E F ， et al . Resveratrol protects against hepatic insulin resistance in a rat’s model of non-alcoholic fatty liver disease by down-regulation of GPAT-1 and DGAT2 expression and inhibition of PKC membranous translocation [J ] . Clin Exp Pharmacol Physiol ， 2019 ， 46 （ 6 ）： 545 - 555 .

ZHUGE H ， PAN Y ， LAI S L ， et al . Penthorum chinense Pursh extract ameliorates alcohol-related fatty liver disease in mice via the SIRT1/AMPK signaling axis [J ] . Heliyon ， 2024 ， 10 （ 11 ）： e31195 .

隆逸瑶，刘渝港，夏会平，等 . 三萜皂苷抗肥胖及其作用机制的研究进展 [J ] . 食品工业科技， 2022 ， 43 （ 7 ）： 445 - 456 .

XIANG Q W ， WEN J Y ， ZHOU Z H ， et al . Effect of hydroxy-α-sanshool on lipid metabolism in liver and hepatocytes based on AMPK signaling pathway [J ] . Phytomedicine ， 2024 ， 132 ： 155849 .

LI Y ， XU S Q ， MIHAYLOVA M M ， et al . AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice [J ] . Cell Metab ， 2011 ， 13 （ 4 ）： 376 - 388 .

FANG S J ， MA Y X ， YANG S H ， et al . The components of Buyang huanwu decoction with UPLC-MS [J ] . Nat Prod Commun ， 2024 ， 19 （ 9 ）： 1934578X241275820 .

ZHANG S C ， CUI Z W ， ZHANG H ， et al . Pea albumin extracted from pea （ Pisum sativum L.） seeds ameliorates high-fat-diet-induced non-alcoholic fatty liver disease by regulating lipogenesis and lipolysis pathways [J ] . Nutrients ， 2024 ， 16 （ 14 ）： 2232 .

RAJENDRAN R ， SUMAN S ， DIVAKARAN S J ， et al . Sesaminol alters phospholipid metabolism and alleviates obesity-induced NAFLD [J ] . FASEB J ， 2024 ， 38 （ 14 ）： e23835 .

YAO W J ， FAN M C ， QIAN H F ， et al . Quinoa polyphenol extract alleviates non-alcoholic fatty liver disease via inhibiting lipid accumulation，inflammation and oxidative stress [J ] . Nutrients ， 2024 ， 16 （ 14 ）： 2276 .

YUAN Z S ， TIAN Y ， ZHANG C ， et al . Integration of systematic review，lipidomics with experiment verification reveals abnormal sphingolipids facilitate diabetic retinopathy by inducing oxidative stress on RMECs [J ] . Biochim Biophys Acta Mol Cell Biol Lipids ， 2023 ， 1868 （ 11 ）： 159382 .

TAN H W ， MI N ， TONG F L ， et al . Lactucopicrin promotes fatty acid β-oxidation and attenuates lipid accumulation through adenosine monophosphate-activated protein kinase activation in free fatty acid-induced human hepatoblastoma cancer cells [J ] . Food Sci Nutr ， 2024 ， 12 （ 8 ）： 5357 - 5372 .

宓伟，于敏，李宁，等 . 基于AMPK/SREBP-1c分子通路的山楂原花青素调控脂质代谢机制 [J ] . 食品科学， 2023 ， 44 （ 15 ）： 129 - 136 .

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Analysis of clinical efficacy of early CRRT combined with nafamostat mesylate for SA-AKI

生血宁和蔗糖铁对血液透析患者贫血、氧化应激及微炎症影响的比较

依达拉奉联合胞磷胆碱钠治疗急性脑梗死的临床观察

可溶性鸟苷酸环化酶激活剂Cinaciguat对高糖环境下人脐静脉内皮细胞的保护作用

依达拉奉联合前列地尔治疗不稳定型心绞痛的临床观察

Related Author

LI Xinhui

XIN Na

YI Ye

LU Yuanhang

JI Qianqian

TAN Qingjing

JI Xing

JIANG Zhibin

Related Institution

Dept. of Critical Care Medicine， Qinghai Provincial People’s Hospital

⁰